BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
103.14
-0.21 (-0.20%)
At close: Nov 7, 2025, 4:00 PM EST
101.75
-1.39 (-1.35%)
After-hours: Nov 7, 2025, 5:15 PM EST
BioNTech SE Stock Forecast
Stock Price Forecast
The 14 analysts that cover BioNTech SE stock have a consensus rating of "Strong Buy" and an average price target of $138.63, which forecasts a 34.41% increase in the stock price over the next year. The lowest target is $110 and the highest is $171.44.
Price Target: $138.63 (+34.41%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 8 | 7 | 7 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $115 → $117 | Hold | Maintains | $115 → $117 | +13.44% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $121 → $120 | Hold | Maintains | $121 → $120 | +16.35% | Oct 23, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $133 → $131 | Buy | Maintains | $133 → $131 | +27.01% | Oct 10, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $116 → $121 | Hold | Maintains | $116 → $121 | +17.32% | Sep 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $136 | Strong Buy | Reiterates | $136 | +31.86% | Sep 8, 2025 |
Financial Forecast
Revenue This Year
2.27B
from 2.75B
Decreased by -17.67%
Revenue Next Year
2.48B
from 2.27B
Increased by 9.49%
EPS This Year
-4.81
from -2.77
EPS Next Year
-3.75
from -4.81
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.5B | 3.4B | |||
| Avg | 2.3B | 2.5B | |||
| Low | 1.6B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.9% | 49.8% | |||
| Avg | -17.7% | 9.5% | |||
| Low | -42.6% | -31.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.16 | 0.11 | |||
| Avg | -4.81 | -3.75 | |||
| Low | -7.53 | -8.00 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.